205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.14%
Revenue growth above 1.5x LSCC's 1.04%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
12.09%
Gross profit growth above 1.5x LSCC's 1.19%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
128.36%
Positive EBIT growth while LSCC is negative. John Neff might see a substantial edge in operational management.
128.36%
Positive operating income growth while LSCC is negative. John Neff might view this as a competitive edge in operations.
119.86%
Net income growth 1.25-1.5x LSCC's 85.18%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
119.44%
EPS growth 1.25-1.5x LSCC's 85.22%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
119.44%
Diluted EPS growth 1.25-1.5x LSCC's 85.22%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
2.54%
Share count expansion well above LSCC's 1.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.54%
Diluted share count expanding well above LSCC's 1.05%. Michael Burry would fear significant dilution to existing owners' stakes.
0.23%
Dividend growth of 0.23% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-73.66%
Negative OCF growth while LSCC is at 2224.60%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-87.40%
Negative FCF growth while LSCC is at 288.57%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1.63%
10Y revenue/share CAGR under 50% of LSCC's 13.86%. Michael Burry would suspect a lasting competitive disadvantage.
-6.45%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-22.48%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
64.62%
10Y OCF/share CAGR 1.25-1.5x LSCC's 56.65%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
506.54%
5Y OCF/share CAGR above 1.5x LSCC's 11.42%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-52.39%
Negative 3Y OCF/share CAGR while LSCC stands at 168.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
26.17%
Positive 10Y CAGR while LSCC is negative. John Neff might see a substantial advantage in bottom-line trajectory.
892.78%
Positive 5Y CAGR while LSCC is negative. John Neff might view this as a strong mid-term relative advantage.
-72.86%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
363.72%
10Y equity/share CAGR 1.25-1.5x LSCC's 297.90%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
67.55%
5Y equity/share CAGR above 1.5x LSCC's 24.12%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-6.45%
Negative 3Y equity/share growth while LSCC is at 81.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
46.91%
Dividend/share CAGR of 46.91% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
4.65%
Dividend/share CAGR of 4.65% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
3.23%
3Y dividend/share CAGR of 3.23% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.16%
AR growth well above LSCC's 16.22%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.65%
We show growth while LSCC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.93%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-20.32%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.97%
Our R&D shrinks while LSCC invests at 370.77%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.51%
SG&A growth well above LSCC's 1.41%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.